Updated:
Fosun Pharma
Fosun Pharma, founded by Guo Guangchang in 1994, is a Shanghai-based pharmaceutical conglomerate deploying capital through R&D and M&A.
Fosun Pharma
Fosun Pharma was founded in 1994 in Shanghai as part of the broader Fosun Group, a conglomerate controlled by Guo Guangchang and fellow co-founders. The firm began as a pharmaceutical trading company and later expanded into R&D, generic drugs, and biopharmaceuticals. The company's strategy covers drug development (small molecules, biologics), medical devices, and diagnostics. Fosun Pharma has invested in oncology, infectious diseases, and chronic conditions, with portfolio highlights including its collaboration with BioNTech on COVID-19 vaccine production in China. Geographically, the firm operates primarily in China, with subsidiaries in Africa and Europe. Fosun Pharma employs roughly 30,000 people globally. The firm maintains additional offices in Hong Kong, New York, and Mumbai, reflecting its international ambitions. A notable recent development: in 2024, Fosun Pharma's subsidiary Fosun Diagnostics launched a new molecular diagnostic platform in China. Structurally, Fosun Pharma is a listed entity on the Hong Kong and Shanghai stock exchanges, distinct from a traditional family office. Its governance combines public market oversight with the strategic direction of the Fosun Group, which functions as a diversified investment holding company controlled by Guo Guangchang.
General information
Firm type
other
Year founded
1994
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Principals
Guo Guangchang
Chairman
Wu Yifang
President
Sector focus
Frequently asked questions
Who controls Fosun Pharma?
Fosun Pharma is part of the Fosun Group, a conglomerate controlled by founder Guo Guangchang and fellow co-founders. The firm is publicly traded on the Hong Kong and Shanghai stock exchanges, so governance is shared with public shareholders.
What is Fosun Pharma's investment focus?
The firm invests across the pharmaceutical value chain, from R&D in oncology and infectious diseases to manufacturing generics and medical devices. It also pursues strategic M&A and partnerships, as seen with the BioNTech vaccine collaboration.
How does Fosun Pharma differ from a traditional family office?
Fosun Pharma is a publicly listed pharmaceutical company, not a family office. It operates under corporate governance with a board and public reporting, though the Fosun Group retains significant influence as a controlling shareholder.
What are Fosun Pharma's main geographic markets?
China is the primary market, but the firm has international operations in Africa, Europe, and the United States. Subsidiaries in Hong Kong, New York, and Mumbai support global distribution.
Does Fosun Pharma have philanthropic or non-profit structures?
The Fosun Group operates the Fosun Foundation, a charitable arm focused on health and education. As a publicly traded entity, Fosun Pharma itself does not maintain a dedicated philanthropy structure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: